首页> 外文OA文献 >Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species▿
【2h】

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species▿

机译:欧洲抗菌药物敏感性试验委员会(EUCAST)和Etest方法与CLSI肉汤微量稀释法对念珠菌物种棘球oc素敏感性试验的比较▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The antifungal broth microdilution (BMD) method of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and the Etest agar diffusion method were compared with the Clinical and Laboratory Standards Institute (CLSI) BMD method M27-A3 for anidulafungin, caspofungin, and micafungin susceptibility testing of 133 clinical isolates of Candida species. The isolates were characterized for the presence or absence of fks1 and/or fks2 gene mutations and included 34 isolates of C. glabrata (4 mutant strains), 32 of C. albicans (1 mutant strain), 25 of C. parapsilosis, 19 of C. guilliermondii, 12 of C. tropicalis (2 mutant strains), and 11 of C. krusei. Excellent essential agreement (EA; within 2 dilutions) between the CLSI and EUCAST and CLSI and Etest MIC results was observed. The overall EA between the EUCAST and CLSI results ranged from 89.5% (caspofungin) to 99.2% (micafungin), whereas the EA between the Etest and CLSI results ranged from 90.2% (caspofungin) to 93.2% (anidulafungin). The categorical agreement (CA) between methods for each antifungal agent was assessed using previously determined epidemiological cutoff values (ECVs). Excellent CA (>90%) was observed for all comparisons between the EUCAST and CLSI results with the exceptions of C. glabrata and caspofungin (85.3%) and C. krusei and caspofungin (54.5%). The CA between the Etest and CLSI results was also excellent for all comparisons, with the exception of C. krusei and caspofungin (81.8%). All three methods were able to differentiate wild-type (WT) strains from those with fks mutations. With anidulafungin as the test reagent, the CLSI method identified 5 of 7 mutant strains, whereas the EUCAST method and the Etest identified 6 of 7 mutant strains. With either caspofungin or micafungin as the test reagent, the CLSI method identified all 7 mutant strains and the EUCAST method identified 6 of 7 mutant strains. The Etest identified all 7 mutant strains using caspofungin as the reagent. All three test methods showed a high level of agreement and of ability to distinguish fks mutant strains of Candida species from WT strains using each of the echinocandins.
机译:将欧洲抗生素敏感性试验委员会(EUCAST)的抗真菌肉汤微稀释(BMD)方法和Etest琼脂扩散法与临床和实验室标准协会(CLSI)的BMD方法M27-A3对阿迪芬净,卡泊芬净和米卡芬净敏感性进行了比较测试133种念珠菌临床分离株。分离株的特征是存在或不存在fks1和/或fks2基因突变,包括34株毛毛衣藻(C. glabrata)(4个突变株),32株白念珠菌(1个突变株),25株副枝梭菌(C. parapsilosis),19株。 guilliermondii C.,C.tropicis(12个突变株)和k.krusei 11个。观察到CLSI与EUCAST和CLSI以及Etest MIC结果之间的极佳基本一致性(EA; 2个稀释度)。 EUCAST和CLSI结果之间的总体EA介于89.5%(卡泊芬净)至99.2%(米卡芬净)之间,而Etest和CLSI结果之间的EA介于90.2%(卡泊芬净)至93.2%(阿尼芬净)之间。使用先前确定的流行病学临界值(ECV)对每种抗真菌药的方法之间的分类一致性(CA)进行了评估。在EUCAST和CLSI结果之间的所有比较中,观察到优良的CA(> 90%),除了光滑毛孢梭菌和卡泊芬净(85.3%)和克鲁赛菌和卡泊芬净(54.5%)。 Etest和CLSI结果之间的CA对所有比较都非常好,除了克鲁氏梭菌和卡泊芬净(81.8%)。这三种方法均能够将野生型(WT)菌株与具有fks突变的菌株区分开。以阿尼芬净为测试试剂,CLSI方法鉴定了7个突变菌株中的5个,而EUCAST方法和Etest鉴定了7个突变菌株中的6个。用卡泊芬净或米卡芬净作为测试试剂,CLSI方法鉴定了所有7个突变菌株,EUCAST方法鉴定了7个突变菌株中的6个。 Etest使用卡泊芬净作为试剂鉴定了所有7个突变菌株。所有这三种测试方法均显示出较高的一致性,并且能够使用每种棘球and素将WT菌株与假丝酵母菌的fks突变菌株区分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号